The quality control division of Randox Laboratories, Crumlin, UK, has expanded its quality control portfolio with the launch of Acusera CSF control. The control consolidates 15 key analytes in a single control, providing laboratories with a third-party solution for the measurement of cerebrospinal fluid while covering a full clinical range. The assayed liquid ready-to-use control has been developed with a 2-year shelf life and open-vial stability of 30 days at 2–8°C. To complement the offering, the company has launched a RIQAS cerebrospinal fluid external quality assessment program. Designed to monitor the control’s performance, the subscription service features liquid ready-to-use samples, testing that covers a range of clinically relevant decision levels, monthly analysis, reports available within 72 hours, and the option to submit results online. For more information, visit AACC booth 2927 or Randox Laboratories.
June 29, 2017